A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma-Reference-Cited by-同舟云学术

A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma

Published:2024-11-11 Issue:1 Volume:14 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Singh Charanpreet,KS Lekshmon^ORCID,Jain Arihant,Lad Deepesh^ORCID,Khadwal Alka,Basher Rajender,Bal Amanjit,Srinivasan Radhika,Varma Subhash,Malhotra Pankaj^ORCID,Prakash Gaurav^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41408-024-01184-7.pdf

Reference13 articles.

1. Borchmann P, Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M, et al. Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial. Lancet 2024;404:341–352.

2. Ansell SM, Radford J, Connors JM, Długosz-Danecka M, Kim W-S, Gallamini A, et al. Overall survival with brentuximab vedotin in stage III or IV Hodgkin’s lymphoma. N Engl J Med. 2022;387:310–20.

3. Luminari S, Fossa A, Trotman J, Molin D, D’Amore F, Enblad G, et al. Long-term follow-up of the response-adjusted therapy for advanced Hodgkin lymphoma trial. J Clin Oncol. 2024;42:13–18.

4. Johnson P, Federico M, Kirkwood A, Fosså A, Berkahn L, Carella A, et al. Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma. N Engl J Med. 2016;374:2419–29.

5. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for Initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–67.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Paraneoplastic Manifestations;Indian Journal of Hematology and Blood Transfusion;2025-04-23